ECSP23034732A - A MAGL INHIBITOR - Google Patents

A MAGL INHIBITOR

Info

Publication number
ECSP23034732A
ECSP23034732A ECSENADI202334732A ECDI202334732A ECSP23034732A EC SP23034732 A ECSP23034732 A EC SP23034732A EC SENADI202334732 A ECSENADI202334732 A EC SENADI202334732A EC DI202334732 A ECDI202334732 A EC DI202334732A EC SP23034732 A ECSP23034732 A EC SP23034732A
Authority
EC
Ecuador
Prior art keywords
compounds
magl
magl inhibitor
useful
compositions
Prior art date
Application number
ECSENADI202334732A
Other languages
Spanish (es)
Inventor
Cheryl Grice
Jeanne Moody
john Wiener
Nicholas Raffaele
Amy Allan
Justin Cisar
Daniel Buzard
Michael Shaghafi
Olivia Weber
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Priority to ECSENADI202334732A priority Critical patent/ECSP23034732A/en
Publication of ECSP23034732A publication Critical patent/ECSP23034732A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En la presente se proporcionan compuestos de 6-azaespiro[2.5]octano-6-carboxilato de 1,1,1,3,3,3-hexafluoropropan2-ilo sustituidos y composiciones farmacéuticas que comprenden dichos compuestos. Los compuestos y composiciones proporcionados en la presente son útiles como inhibidores de MAGL. Además, los compuestos y composiciones proporcionados en la presente son útiles para el tratamiento de enfermedades y trastornos que se benefician de la inhibición de MAGL.Provided herein are substituted 1,1,1,3,3,3-hexafluoropropan2-yl 6-azaspiro[2.5]octane-6-carboxylate compounds and pharmaceutical compositions comprising such compounds. The compounds and compositions provided herein are useful as MAGL inhibitors. Furthermore, the compounds and compositions provided herein are useful for the treatment of diseases and disorders that benefit from the inhibition of MAGL.

ECSENADI202334732A 2023-05-10 2023-05-10 A MAGL INHIBITOR ECSP23034732A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSENADI202334732A ECSP23034732A (en) 2023-05-10 2023-05-10 A MAGL INHIBITOR

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSENADI202334732A ECSP23034732A (en) 2023-05-10 2023-05-10 A MAGL INHIBITOR

Publications (1)

Publication Number Publication Date
ECSP23034732A true ECSP23034732A (en) 2023-06-30

Family

ID=88414629

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202334732A ECSP23034732A (en) 2023-05-10 2023-05-10 A MAGL INHIBITOR

Country Status (1)

Country Link
EC (1) ECSP23034732A (en)

Similar Documents

Publication Publication Date Title
CL2023001339A1 (en) A magl inhibitor.
MX2023013339A (en) Complement factor b inhibitor, and pharmaceutical composition thereof, preparation method therefor and use thereof.
MX2024001894A (en) Heterocyclic compounds and methods of use.
CO2026004964A2 (en) Kras modulators
CL2020002146A1 (en) N- (phenyl) -2- (phenyl) pyrimidine-4-carboxamide derivatives and related compounds as hpki inhibitors to treat cancer.
CO2024012743A2 (en) 6-oxodecahydropyrrolo[1,2-a][1,5]diazocine and 6-oxodecahydro-4h-pyrrolo[2,1-d][1,5]thiazocine derivatives as stat3 and stat6 modulators for the treatment of cancer and inflammatory conditions
CL2022003360A1 (en) Substituted benzofuran, benzopyrrole, benzothiophene and other structurally related complement inhibitors (application divisional 202002578)
MX2020007947A (en) ERBB/BTK INHIBITORS.
UY28691A1 (en) DERIVATIVES OF DIFENILAZETIDONA
UY27882A1 (en) CHEMICAL COMPOUNDS
CL2023002223A1 (en) CDK2 inhibitors and methods of their use
CO2022011258A2 (en) Substituted pyrazolo-pyrimidines and uses thereof
CO2024006727A2 (en) Macrocyclic compounds and compositions, and methods for preparing and using the same
MX2022011697A (en) Cyclophilin inhibitors and uses thereof.
MX2022013081A (en) COMPOUNDS FOR THE TREATMENT OF SARS.
AR127470A1 (en) LRRK2 INHIBITORS
CR20220280A (en) COMBINATION THERAPY COMPRISING AN ALK2 INHIBITOR AND A JAK2 INHIBITOR
PY2126225A (en) PYRROLOPYRIMIDINAMINES AS INHIBITORS OF THE COMPLEMENT SYSTEM
BR112022003768A2 (en) PERK INHIBITOR COMPOUNDS
CO2025003263A2 (en) Kif18a inhibitors and their uses
MX2023003731A (en) 3-[(1h-pyrazol-4-yl)oxy]pyrazin-2-amine compounds as hpk1 inhibitor and use thereof.
ECSP23034732A (en) A MAGL INHIBITOR
CL2024002500A1 (en) Inhibitors of emopamil binding proteins and their uses
ECSP23088732A (en) TREX1 MODULATORS
AR127127A1 (en) NEW PYRIDODIAZEPINE DERIVATIVES LIKE GABAA PAM g1